- Exchange: OTC US
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Sophiris Bio Inc
+ Add to WatchlistPTXRF:US
0.2680 USD 0.00000.00%As of 20:10:00 ET on 05/17/2013.
Snapshot for Sophiris Bio Inc (PTXRF)
| Open: | - | Day's Range: | - | Volume: | 1,000 |
|---|---|---|---|---|---|
| Previous Close: | 0.2680 | 52wk Range: | 0.1730 - 0.4150 | 1-Yr Rtn: | -18.04% |
Key Statistics for PTXRF
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (CAD) (ttm) | - |
| Est. EPS (CAD) (12/2013) | -0.0300 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 14,095 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/13/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for PTXRF
Company Profile & Key Executives for PTXRF
Sophiris Bio Inc. is a biotechnology company. The Company has developed technologies that can lead to therapeutic products. Sophiris expects to target cancers such as lung cancer, Non-Hodgkin's lymphoma, and breast cancer.
| Lars G EkmanChairman/President | Randall E WoodsPresident/CEO |
| Allison HulmeChief Operating Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
PTXRF News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page